scholarly article | Q13442814 |
P50 | author | Ita Pfeferman Heilberg | Q67189767 |
P2093 | author name string | Giovanni Gambaro | |
Glenn M Preminger | |||
Pietro Manuel Ferraro | |||
Daniel A Wollin | |||
Antonio Nouvenne | |||
Adam G Kaplan | |||
Andrea Tasca | |||
Emanuele Croppi | |||
P2860 | cites work | Medical management of kidney stones: AUA guideline | Q28240681 |
When is medical prophylaxis cost-effective for recurrent calcium stones? | Q30843922 | ||
Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis | Q31931080 | ||
Metabolic evaluation of first-time and recurrent stone formers | Q33737379 | ||
Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers. | Q33835734 | ||
Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians | Q34445981 | ||
The ROKS nomogram for predicting a second symptomatic stone episode | Q34568756 | ||
Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation | Q34657936 | ||
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones | Q34730506 | ||
Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study | Q34732675 | ||
Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones | Q35373518 | ||
Nephrolithiasis: why doesn't our "learning" progress? | Q35744855 | ||
Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic | Q35788301 | ||
Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis | Q36768914 | ||
RANKL is a mediator of bone resorption in idiopathic hypercalciuria. | Q36843360 | ||
Evaluation of the recurrent stone former | Q36902341 | ||
Asymptomatic nephrolithiasis detected by ultrasound | Q37123160 | ||
Evidence for durable kidney stone prevention over several decades | Q37401624 | ||
Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis | Q37475818 | ||
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers | Q38037888 | ||
Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: AUA technology assessment | Q38053773 | ||
Optimum nutrition for kidney stone disease | Q38084518 | ||
Digital Tomosynthesis: A Viable Alternative to Noncontrast Computed Tomography for the Follow-Up of Nephrolithiasis? | Q38808284 | ||
Digital tomosynthesis in the detection of urolithiasis: Diagnostic performance and dosimetry compared with digital radiography with MDCT as the reference standard. | Q39938570 | ||
Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis | Q42966934 | ||
A nomogram for the prediction of kidney stone recurrence | Q43030405 | ||
Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis | Q43589877 | ||
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism | Q43619329 | ||
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria | Q43850214 | ||
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions | Q44288956 | ||
Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice | Q44686649 | ||
An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-L goal urine volume | Q45841973 | ||
Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey | Q48662799 | ||
Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. | Q50748162 | ||
Fracture risk among patients with urolithiasis: a population-based cohort study. | Q50908960 | ||
Natural history of asymptomatic renal stones and prediction of stone related events. | Q51292398 | ||
Should patients with single renal stone occurrence undergo diagnostic evaluation? | Q51650964 | ||
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. | Q53672108 | ||
How physician and patient perceptions differ regarding medical management of stone disease. | Q54328061 | ||
Medical reduction of stone risk in a network of treatment centers compared to a research clinic | Q58118326 | ||
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study | Q70279032 | ||
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients | Q70303959 | ||
Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy | Q72820917 | ||
A prospective study of nonmedical prophylaxis after a first kidney stone | Q78196175 | ||
Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy | Q80166446 | ||
24-hour urine collection in the metabolic evaluation of stone formers: is one study adequate? | Q84960641 | ||
Prevalence of 24-hour urine collection in high risk stone formers | Q85705663 | ||
Beyond belief--how people feel about taking medications for heart disease | Q86487017 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 8 | |
P304 | page(s) | 235-242 | |
P577 | publication date | 2018-10-01 | |
P1433 | published in | Asian Journal of Urology | Q50807185 |
P1476 | title | Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers | |
P478 | volume | 5 |
Q90393771 | Calcium Kidney Stones are Associated with Increased Risk of Carotid Atherosclerosis: The Link between Urinary Stone Risks, Carotid Intima-Media Thickness, and Oxidative Stress Markers | cites work | P2860 |
Search more.